G-CSF-activated STAT3 enhances production of the chemokine MIP-2 in bone marrow neutrophils

Journal of Leukocyte Biology

Volumn 92, Issue 6, 2012, Pages 1215-1225

  Nguyen Jackson, Hoainam T ^a,b   Li, Haiyan S ^a   Zhang, Huiyuan ^a   Ohashi, Erika ^a   Watowich, Stephanie S ^a,b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

Chemotaxis; Chromatin; Transcription

Indexed keywords

CXCL2 CHEMOKINE; GRANULOCYTE COLONY STIMULATING FACTOR; MACROPHAGE INFLAMMATORY PROTEIN 2; MESSENGER RNA; RNA; STAT3 PROTEIN;

ANIMAL CELL; ARTICLE; BONE MARROW; CONTROLLED STUDY; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BONE MARROW CELLS; CELL LINE; CHEMOKINE CXCL2; CHROMATIN ASSEMBLY AND DISASSEMBLY; GENE EXPRESSION REGULATION; GRANULOCYTE COLONY-STIMULATING FACTOR; HISTONES; IMMUNOPHENOTYPING; MICE; MICE, KNOCKOUT; NEUTROPHILS; PROMOTER REGIONS, GENETIC; RECEPTORS, CELL SURFACE; RECEPTORS, INTERLEUKIN-8B; RNA POLYMERASE II; STAT3 TRANSCRIPTION FACTOR; TRANSCRIPTIONAL ACTIVATION;

EID: 84870411737     PISSN: 07415400     EISSN: 19383673     Source Type: Journal    
DOI: 10.1189/jlb.0312126     Document Type: Article

References (82)

1. Lord, B. I., Bronchud, M. H., Owens, S., Chang, J., Howell, A., Souza, L., Dexter, T. M. (1989) The kinetics of human granulopoiesis following treatment with granulocyte colony-stimulating factor in vivo. Proc. Natl. Acad. Sci. USA 86, 9499-9503.
2. Lord, B. I., Molineux, G., Pojda, Z., Souza, L. M., Mermod, J. J., Dexter, T. M. (1991) Myeloid cell kinetics in mice treated with recombinant interleukin-3, granulocyte colony-stimulating factor (CSF), or granulocytemacrophage CSF in vivo. Blood 77, 2154-2159.
3. Lieschke, G. J., Grail, D., Hodgson, G., Metcalf, D., Stanley, E., Cheers, C., Fowler, K. J., Basu, S., Zhan, Y. F., Dunn, A. R. (1994) Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization. Blood 84, 1737-1746.
4. Nicola, N. A., Metcalf, D., Matsumoto, M., Johnson, G. R. (1983) Purification of a factor inducing differentiation in murine myelomonocytic leukemia cells. Identification as granulocyte colony-stimulating factor. J. Biol. Chem. 258, 9017-9023.
5. Cheers, C., Haigh, A. M., Kelso, A., Metcalf, D., Stanley, E. R., Young, A. M. (1988) Production of colony-stimulating factors (CSFs) during infection: separate determinations of macrophage-, granulocyte-, granulocyte-macrophage-, and multi-CSFs. Infect. Immun. 56, 247-251.
6. Furze, R. C., Rankin, S. M. (2008) Neutrophil mobilization and clearance in the bone marrow. Immunology 125, 281-288.
7. Bhana, N. (2007) Granulocyte colony-stimulating factors in the management of chemotherapy-induced neutropenia: evidence based review. Curr. Opin. Oncol. 19, 328-335.
8. Welte, K., Gabrilove, J., Bronchud, M. H., Platzer, E., Morstyn, G. (1996) Filgrastim (r-metHuG-CSF): the first 10 years. Blood 88, 1907-1929.
9. Eyles, J. L., Hickey, M. J., Norman, M. U., Croker, B. A., Roberts, A. W., Drake, S. F., James, W. G., Metcalf, D., Campbell, I. K., Wicks, I. P. (2008) A key role for G-CSF-induced neutrophil production and trafficking during inflammatory arthritis. Blood 112, 5193-5201.
10. Beekman, R., Touw, I. P. (2010) G-CSF and its receptor in myeloid malignancy. Blood 115, 5131-5136.
11. Nicola, N. A., Metcalf, D. (1985) Binding of 125I-labeled granulocyte colony-stimulating factor to normal murine hemopoietic cells. J. Cell. Physiol. 124, 313-321.
12. Nicholson, S. E., Oates, A. C., Harpur, A. G., Ziemiecki, A., Wilks, A. F., Layton, J. E. (1994) Tyrosine kinase JAK1 is associated with the granulocyte-colony-stimulating factor receptor and both become tyrosine-phosphorylated after receptor activation. Proc. Natl. Acad. Sci. USA 91, 2985-2988.
13. Tian, S. S., Lamb, P., Seidel, H. M., Stein, R. B., Rosen, J. (1994) Rapid activation of the STAT3 transcription factor by granulocyte colony-stimulating factor. Blood 84, 1760-1764.
14. Shimoda, K., Feng, J., Murakami, H., Nagata, S., Watling, D., Rogers, N. C., Stark, G. R., Kerr, I. M., Ihle, J. N. (1997) Jak1 plays an essential role for receptor phosphorylation and Stat activation in response to granulocyte colony-stimulating factor. Blood 90, 597-604.
15. Tian, S. S., Tapley, P., Sincich, C., Stein, R. B., Rosen, J., Lamb, P. (1996) Multiple signaling pathways induced by granulocyte colony-stimulating factor involving activation of JAKs, STAT5, and/or STAT3 are required for regulation of three distinct classes of immediate early genes. Blood 88, 4435-4444.
16. Chakraborty, A., Dyer, K. F., Cascio, M., Mietzner, T. A., Tweardy, D. J. (1999) Identification of a novel Stat3 recruitment and activation motif within the granulocyte colony-stimulating factor receptor. Blood 93, 15-24.
17. De Koning, J. P., Soede-Bobok, A. A., Schelen, A. M., Smith, L., van Leeuwen, D., Santini, V., Burgering, B. M., Bos, J. L., Lowenberg, B., Touw, I. P. (1998) Proliferation signaling and activation of Shc, p21Ras, and Myc via tyrosine 764 of human granulocyte colony-stimulating factor receptor. Blood 91, 1924-1933.
18. McLemore, M. L., Grewal, S., Liu, F., Archambault, A., Poursine-Laurent, J., Haug, J., Link, D. C. (2001) STAT-3 activation is required for normal G-CSF-dependent proliferation and granulocytic differentiation. Immunity 14, 193-204.
19. Lee, C. K., Raz, R., Gimeno, R., Gertner, R., Wistinghausen, B., Takeshita, K., DePinho, R. A., Levy, D. E. (2002) STAT3 is a negative regulator of granulopoiesis but is not required for G-CSF-dependent differentiation. Immunity 17, 63-72.
20. Panopoulos, A. D., Zhang, L., Snow, J. W., Jones, D. M., Smith, A. M., El Kasmi, K. C., Liu, F., Goldsmith, M. A., Link, D. C., Murray, P. J., Watowich, S. S. (2006) STAT3 governs distinct pathways in emergency granulopoiesis and mature neutrophils. Blood 108, 3682-3690.
21. Zhang, H., Nguyen-Jackson, H., Panopoulos, A. D., Li, H. S., Murray, P. J., Watowich, S. S. (2010) STAT3 controls myeloid progenitor growth during emergency granulopoiesis. Blood 116, 2462-2471.
22. Nguyen-Jackson, H., Panopoulos, A. D., Zhang, H., Li, H. S., Watowich, S. S. (2010) STAT3 controls the neutrophil migratory response to CXCR2 ligands by direct activation of G-CSF-induced CXCR2 expression and via modulation of CXCR2 signal transduction. Blood 115, 3354-3363.
23. Croker, B. A., Metcalf, D., Robb, L., Wei, W., Mifsud, S., DiRago, L., Cluse, L. A., Sutherland, K. D., Hartley, L., Williams, E., Zhang, J. G., Hilton, D. J., Nicola, N. A., Alexander, W. S., Roberts, A. W. (2004) SOCS3 is a critical physiological negative regulator of G-CSF signaling and emergency granulopoiesis. Immunity 20, 153-165.
24. Minegishi, Y., Saito, M., Tsuchiya, S., Tsuge, I., Takada, H., Hara, T., Kawamura, N., Ariga, T., Pasic, S., Stojkovic, O., Metin, A., Karasuyama, H. (2007) Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Nature 448, 1058-1062.
25. Holland, S. M., DeLeo, F. R., Elloumi, H. Z., Hsu, A. P., Uzel, G., Brodsky, N., Freeman, A. F., Demidowich, A., Davis, J., Turner, M. L., Anderson, V. L., Darnell, D. N., Welch, P. A., Kuhns, D. B., Frucht, D. M., Malech, H. L., Gallin, J. I., Kobayashi, S. D., Whitney, A. R., Voyich, J. M., Musser, J. M., Woellner, C., Schaffer, A. A., Puck, J. M., Grimbacher, B. (2007) STAT3 mutations in the hyper-IgE syndrome. N. Engl. J. Med. 357, 1608-1619.
26. Wengner, A. M., Pitchford, S. C., Furze, R. C., Rankin, S. M. (2008) The coordinated action of G-CSF and ELR + CXC chemokines in neutrophil mobilization during acute inflammation. Blood 111, 42-49.
27. Pelus, L. M., Horowitz, D., Cooper, S. C., King, A. G. (2002) Peripheral blood stem cell mobilization. A role for CXC chemokines. Crit. Rev. Oncol. Hematol. 43, 257-275.
28. Cacalano, G., Lee, J., Kikly, K., Ryan, A. M., Pitts-Meek, S., Hultgren, B., Wood, W. I., Moore, M. W. (1994) Neutrophil and B cell expansion in mice that lack the murine IL-8 receptor homolog. Science 265, 682-684.
29. O'Brien, T., Hardin, S., Greenleaf, A., Lis, J. T. (1994) Phosphorylation of RNA polymerase II C-terminal domain and transcriptional elongation. Nature 370, 75-77.
30. Svejstrup, J. Q. (2004) The RNA polymerase II transcription cycle: cycling through chromatin. Biochim. Biophys. Acta 1677, 64-73.
31. Komarnitsky, P., Cho, E. J., Buratowski, S. (2000) Different phosphorylated forms of RNA polymerase II and associated mRNA processing factors during transcription. Genes Dev. 14, 2452-2460.
32. Agger, K., Christensen, J., Cloos, P. A., Helin, K. (2008) The emerging functions of histone demethylases. Curr. Opin. Genet. Dev. 18, 159-168.
33. Berger, S. L. (2007) The complex language of chromatin regulation during transcription. Nature 447, 407-412.
34. Chan, H. M., La Thangue, N. B. (2001) p300/CBP proteins: HATs for transcriptional bridges and scaffolds. J. Cell Sci. 114, 2363-2373.
35. Gray, M. J., Zhang, J., Ellis, L. M., Semenza, G. L., Evans, D. B., Watowich, S. S., Gallick, G. E. (2005) HIF-1α, STAT3, CBP/p300 and. Ref-1/APE are components of a transcriptional complex that regulates Srcdependent hypoxia-induced expression of VEGF in pancreatic and prostate carcinomas. Oncogene. 24, 3110-3120.
36. Farlik, M., Reutterer, B., Schindler, C., Greten, F., Vogl, C., Muller, M., Decker, T. (2010) Nonconventional initiation complex assembly by STAT and NF-κB transcription factors regulates nitric oxide synthase expression. Immunity 33, 25-34.
37. Dawson, M. A., Bannister, A. J., Gottgens, B., Foster, S. D., Bartke, T., Green, A. R., Kouzarides, T. (2009) JAK2 phosphorylates histone H3Y41 and excludes HP1α from chromatin. Nature 461, 819-822.
38. Yang, J., Huang, J., Dasgupta, M., Sears, N., Miyagi, M., Wang, B., Chance, M. R., Chen, X., Du, Y., Wang, Y., An, L., Wang, Q., Lu, T., Zhang, X., Wang, Z., Stark, G. R. (2010) Reversible methylation of promoter-bound STAT3 by histone-modifying enzymes. Proc. Natl. Acad. Sci. USA 107, 21499-21504.
39. Wei, L., Vahedi, G., Sun, H. W., Watford, W. T., Takatori, H., Ramos, H. L., Takahashi, H., Liang, J., Gutierrez-Cruz, G., Zang, C., Peng, W., O'Shea, J. J., Kanno, Y. (2010) Discrete roles of STAT4 and STAT6 transcription factors in tuning epigenetic modifications and transcription during T helper cell differentiation. Immunity 32, 840-851.
40. Griffiths, D. S., Li, J., Dawson, M. A., Trotter, M. W., Cheng, Y. H., Smith, A. M., Mansfield, W., Liu, P., Kouzarides, T., Nichols, J., Bannister, A. J., Green, A. R., Gottgens, B. (2011) LIF-independent JAK signalling to chromatin in embryonic stem cells uncovered from an adult stem cell disease. Nat. Cell Biol. 13, 13-21.
41. Saxena, N. K., Vertino, P. M., Anania, F. A., Sharma, D. (2007) Leptininduced growth stimulation of breast cancer cells involves recruitment of histone acetyltransferases and mediator complex to CYCLIN D1 promoter via activation of Stat3. J. Biol. Chem. 282, 13316-13325.
42. Paulson, M., Pisharody, S., Pan, L., Guadagno, S., Mui, A. L., Levy, D. E. (1999) Stat protein transactivation domains recruit p300/CBP through widely divergent sequences. J. Biol. Chem. 274, 25343-25349.
43. Zhang, Q., Wang, H. Y., Marzec, M., Raghunath, P. N., Nagasawa, T., Wasik, M. A. (2005) STAT3- and DNA methyltransferase 1-mediated epigenetic silencing of SHP-1 tyrosine phosphatase tumor suppressor gene in malignant T lymphocytes. Proc. Natl. Acad. Sci. USA 102, 6948-6953.
44. Hestdal, K., Ruscetti, F. W., Ihle, J. N., Jacobsen, S. E., Dubois, C. M., Kopp, W. C., Longo, D. L., Keller, J. R. (1991) Characterization and regulation of RB6-8C5 antigen expression on murine bone marrow cells. J. Immunol. 147, 22-28.
45. Esashi, E., Wang, Y. H., Perng, O., Qin, X. F., Liu, Y. J., Watowich, S. S. (2008) The signal transducer STAT5 inhibits plasmacytoid dendritic cell development by suppressing transcription factor IRF8. Immunity 28, 509-520.
46. Zhang, L., Badgwell, D. B., Bevers III, J. J., Schlessinger, K., Murray, P. J., Levy, D. E., Watowich, S. S. (2006) IL-6 signaling via the STAT3/SOCS3 pathway: functional analysis of the conserved STAT3 N-domain. Mol. Cell. Biochem. 288, 179-189.
47. Wooten, D. K., Xie, X., Bartos, D., Busche, R. A., Longmore, G. D., Watowich, S. S. (2000) Cytokine signaling through Stat3 activates integrins, promotes adhesion, and induces growth arrest in the myeloid cell line 32D. J. Biol. Chem. 275, 26566-26575.
48. Sudo, T., Nishikawa, S., Ogawa, M., Kataoka, H., Ohno, N., Izawa, A., Hayashi, S. (1995) Functional hierarchy of c-kit and c-fms in intramarrow production of CFU-M. Oncogene 11, 2469-2476.
49. Martin, C., Burdon, P. C., Bridger, G., Gutierrez-Ramos, J. C., Williams, T. J., Rankin, S. M. (2003) Chemokines acting via CXCR2 and CXCR4 control the release of neutrophils from the bone marrow and their return following senescence. Immunity 19, 583-593.
50. Eash, K. J., Greenbaum, A. M., Gopalan, P. K., Link, D. C. (2010) CXCR2 and CXCR4 antagonistically regulate neutrophil trafficking from murine bone marrow. J. Clin. Invest. 120, 2423-2431.
51. Panopoulos, A. D., Bartos, D., Zhang, L., Watowich, S. S. (2002) Control of myeloid-specific integrin α Mβ 2 (CD11b/CD18) expression by cytokines is regulated by Stat3-dependent activation of PU. 1. J. Biol. Chem. 277, 19001-19007.
52. Auernhammer, C. J., Bousquet, C., Melmed, S. (1999) Autoregulation of pituitary corticotroph SOCS-3 expression: characterization of the murine SOCS-3 promoter. Proc. Natl. Acad. Sci. USA 96, 6964-6969.
53. Strahl, B. D., Allis, C. D. (2000) The language of covalent histone modifications. Nature 403, 41-45.
54. Jenuwein, T., Allis, C. D. (2001) Translating the histone code. Science 293, 1074-1080.
55. Rice, J. C., Allis, C. D. (2001) Histone methylation versus histone acetylation: new insights into epigenetic regulation. Curr. Opin. Cell Biol. 13, 263-273.
56. Mikkelsen, T. S., Ku, M., Jaffe, D. B., Issac, B., Lieberman, E., Giannoukos, G., Alvarez, P., Brockman, W., Kim, T. K., Koche, R. P., Lee, W., Mendenhall, E., O'Donovan, A., Presser, A., Russ, C., Xie, X., Meissner, A., Wernig, M., Jaenisch, R., Nusbaum, C., Lander, E. S., Bernstein, B. E. (2007) Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature 448, 553-560.
57. Bernstein, B. E., Mikkelsen, T. S., Xie, X., Kamal, M., Huebert, D. J., Cuff, J., Fry, B., Meissner, A., Wernig, M., Plath, K., Jaenisch, R., Wagschal, A., Feil, R., Schreiber, S. L., Lander, E. S. (2006) A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 125, 315-326.
58. Semerad, C. L., Liu, F., Gregory, A. D., Stumpf, K., Link, D. C. (2002) G-CSF is an essential regulator of neutrophil trafficking from the bone marrow to the blood. Immunity 17, 413-423.
59. Watanabe, T., Kawano, Y., Kanamaru, S., Onishi, T., Kaneko, S., Wakata, Y., Nakagawa, R., Makimoto, A., Kuroda, Y., Takaue, Y., Talmadge, J. E. (1999) Endogenous interleukin-8 (IL-8) surge in granulocyte colonystimulating factor-induced peripheral blood stem cell mobilization. Blood 93, 1157-1163.
60. Gharavi, N. M., Alva, J. A., Mouillesseaux, K. P., Lai, C., Yeh, M., Yeung, W., Johnson, J., Szeto, W. L., Hong, L., Fishbein, M., Wei, L., Pfeffer, L. M., Berliner, J. A. (2007) Role of the Jak/STAT pathway in the regulation of interleukin-8 transcription by oxidized phospholipids in vitro and in atherosclerosis in vivo. J. Biol. Chem. 282, 31460-31468.
61. Kohler, A., De Filippo, K., Hasenberg, M., van den Brandt, C., Nye, E., Hosking, M. P., Lane, T. E., Mann, L., Ransohoff, R. M., Hauser, A. E., Winter, O., Schraven, B., Geiger, H., Hogg, N., Gunzer, M. (2011) GCSF-mediated thrombopoietin release triggers neutrophil motility and mobilization from bone marrow via induction of Cxcr2 ligands. Blood 117, 4349-4357.
62. Darnell J. E., Jr., (1997) STATs and gene regulation. Science 277, 1630-1635.
63. Darnell J. E., Jr., Kerr, I. M., Stark, G. R. (1994) Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264, 1415-1421.
64. Cheon, H., Yang, J., Stark, G. R. (2011) The functions of signal transducers and activators of transcriptions 1 and 3 as cytokine-inducible proteins. J. Interferon Cytokine Res. 31, 33-40.
65. Stark, G. R. (2007) How cells respond to interferons revisited: from early history to current complexity. Cytokine Growth Factor Rev. 18, 419-423.
66. O'Shea, J. J., Lahesmaa, R., Vahedi, G., Laurence, A., Kanno, Y. (2011) Genomic views of STAT function in CD4+ T helper cell differentiation. Nat. Rev. Immunol. 11, 239-250.
67. Dahmus, M. E. (1996) Reversible phosphorylation of the C-terminal domain of RNA polymerase II. J. Biol. Chem. 271, 19009-19012.
68. Weeks, J. R., Hardin, S. E., Shen, J., Lee, J. M., Greenleaf, A. L. (1993) Locus-specific variation in phosphorylation state of RNA polymerase II in vivo: correlations with gene activity and transcript processing. Genes Dev. 7, 2329-2344.
69. Feaver, W. J., Svejstrup, J. Q., Henry, N. L., Kornberg, R. D. (1994) Relationship of CDK-activating kinase and RNA polymerase II CTD kinase TFIIH/TFIIK. Cell 79, 1103-1109.
70. Vo, N., Goodman, R. H. (2001) CREB-binding protein and p300 in transcriptional regulation. J. Biol. Chem. 276, 13505-13508.
71. Santos-Rosa, H., Schneider, R., Bannister, A. J., Sherriff, J., Bernstein, B. E., Emre, N. C., Schreiber, S. L., Mellor, J., Kouzarides, T. (2002) Active genes are tri-methylated at K4 of histone H3. Nature 419, 407-411.
72. Ruthenburg, A. J., Allis, C. D., Wysocka, J. (2007) Methylation of lysine 4 on histone H3: intricacy of writing and reading a single epigenetic mark. Mol. Cell. 25, 15-30.
73. Ng, H. H., Robert, F., Young, R. A., Struhl, K. (2003) Targeted recruitment of Set1 histone methylase by elongating Pol II provides a localized mark and memory of recent transcriptional activity. Mol. Cell. 11, 709-719.
74. Crump, N. T., Hazzalin, C. A., Bowers, E. M., Alani, R. M., Cole, P. A., Mahadevan, L. C. (2011) Dynamic acetylation of all lysine-4 trimethylated histone H3 is evolutionarily conserved and mediated by p300/CBP. Proc. Natl. Acad. Sci. USA 108, 7814-7819.
75. Sims, R. J., 3rd, Nishioka, K., Reinberg, D. (2003) Histone lysine methylation: a signature for chromatin function. Trends Genet. 19, 629-639.
76. Cao, R., Wang, L., Wang, H., Xia, L., Erdjument-Bromage, H., Tempst, P., Jones, R. S., Zhang, Y. (2002) Role of histone H3 lysine 27 methylation in Polycomb-group silencing. Science 298, 1039-1043.
77. Kuzmichev, A., Nishioka, K., Erdjument-Bromage, H., Tempst, P., Reinberg, D. (2002) Histone methyltransferase activity associated with a human multiprotein complex containing the Enhancer of Zeste protein. Genes Dev. 16, 2893-2905.
78. Hansen, K. H., Bracken, A. P., Pasini, D., Dietrich, N., Gehani, S. S., Monrad, A., Rappsilber, J., Lerdrup, M., Helin, K. (2008) A model for transmission of the H3K27me3 epigenetic mark. Nat. Cell Biol. 10, 1291-1300.
79. Majewski, I. J., Blewitt, M. E., de Graaf, C. A., McManus, E. J., Bahlo, M., Hilton, A. A., Hyland, C. D., Smyth, G. K., Corbin, J. E., Metcalf, D., Alexander, W. S., Hilton, D. J. (2008) Polycomb repressive complex 2 (PRC2) restricts hematopoietic stem cell activity. PLoS Biol. 6, e93.
80. Majewski, I. J., Ritchie, M. E., Phipson, B., Corbin, J., Pakusch, M., Ebert, A., Busslinger, M., Koseki, H., Hu, Y., Smyth, G. K., Alexander, W. S., Hilton, D. J., Blewitt, M. E. (2010) Opposing roles of polycomb repressive complexes in hematopoietic stem and progenitor cells. Blood 116, 731-739.
81. Cloos, P. A., Christensen, J., Agger, K., Helin, K. (2008) Erasing the methyl mark: histone demethylases at the center of cellular differentiation and disease. Genes Dev. 22, 1115-1140.
82. De Santa, F., Totaro, M. G., Prosperini, E., Notarbartolo, S., Testa, G., Natoli, G. (2007) The histone H3 lysine-27 demethylase Jmjd3 links inflammation to inhibition of polycomb-mediated gene silencing. Cell 130, 1083-1094.